Your session is about to expire
← Back to Search
Procedure
Digital nerve procedure for Pain (PAPDAP Trial)
N/A
Waitlist Available
Led By Scott N Loewenstein, MD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up tinel's sign at 3 months; tinel's sign at 6 months
Awards & highlights
PAPDAP Trial Summary
This trial will compare three treatments for nerve pain after finger amputation: targeted muscle reinnervation (TMR), regenerative peripheral nerve interfaces (RPNI), and standard traction neurectomy (TN).
Eligible Conditions
- Pain
- Neuroma
- Amputation
PAPDAP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ tinel's sign at 3 months; tinel's sign at 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~tinel's sign at 3 months; tinel's sign at 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
bMHQ
Secondary outcome measures
Grip strength
NPS
Other outcome measures
Tinel's sign
PAPDAP Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Targeted Muscle ReinnervationExperimental Treatment1 Intervention
Targeted Muscle Reinnervation - of digital sensory nerves at the time of amputation
Group II: Regenerative Peripheral Nerve InterfaceExperimental Treatment1 Intervention
Regenerative Peripheral Nerve Interface - of digital sensory nerves at the time of amputation
Group III: Traction NeurectomyActive Control1 Intervention
Traction neurectomy - of digital sensory nerves at the time of amputation.
Find a Location
Who is running the clinical trial?
Indiana UniversityLead Sponsor
993 Previous Clinical Trials
1,095,244 Total Patients Enrolled
6 Trials studying Pain
1,770 Patients Enrolled for Pain
American Society for Surgery of the HandOTHER
10 Previous Clinical Trials
1,042 Total Patients Enrolled
Scott N Loewenstein, MDPrincipal InvestigatorIndiana University
Share this study with friends
Copy Link
Messenger